Vertex Pharmaceuticals (VRTX) Total Debt (QoQ) (2010 - 2016)
Vertex Pharmaceuticals (VRTX) Total Debt (QoQ) (2010 - 2016) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Alnylam Pharmaceuticals | 36.08 Bn | 33.07 Bn | 959.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2016 | -74.81% |
| Sep 30, 2016 | 0.42% |
| Jun 30, 2016 | 0.23% |
| Mar 31, 2016 | 32.14% |
| Dec 31, 2015 | -24.07% |
| Sep 30, 2015 | 0.01% |
| Jun 30, 2015 | 0.01% |
| Mar 31, 2015 | 0.01% |
| Dec 31, 2014 | 0.01% |
| Mar 31, 2011 | 43.88% |
| Dec 31, 2010 | 202.54% |
| Sep 30, 2010 | -72.33% |